VeriMomtetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate, 아기 피부에 안전한가요?
No infant-specific toxicity or dermal absorption studies were found. Peptide active (high MW, water‑soluble glycerin formulations) suggests low systemic absorption in adults (adult e=0). Per scoring rules, because adult absorption is not demonstrably zero and infant skin has higher permeability, exposure for 0–3 yr is conservatively increased by +1 to e=1. No data were found to increase hazard (h) or mechanism (m) scores for infants. Sources: DSM Syn‑HYCAN brochure, EPA CompTox, EWG listing noting concern but not providing reproductive/infant data.
Also relevant: pregnancy safety
Want to know if tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate is also safe during pregnancy?
Is tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate safe during pregnancy? →Gentle products containing tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate
Frequently asked questions
- tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate, 아기 피부에 안전한가요?
- No infant-specific toxicity or dermal absorption studies were found. Peptide active (high MW, water‑soluble glycerin formulations) suggests low systemic absorption in adults (adult e=0). Per scoring rules, because adult absorption is not demonstrably zero and infant skin has higher permeability, exposure for 0–3 yr is conservatively increased by +1 to e=1. No data were found to increase hazard (h) or mechanism (m) scores for infants. Sources: DSM Syn‑HYCAN brochure, EPA CompTox, EWG listing noting concern but not providing reproductive/infant data.
- tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate, 신생아에게 안전한가요?
- No infant-specific toxicity or dermal absorption studies were found. Peptide active (high MW, water‑soluble glycerin formulations) suggests low systemic absorption in adults (adult e=0). Per scoring rules, because adult absorption is not demonstrably zero and infant skin has higher permeability, exposure for 0–3 yr is conservatively increased by +1 to e=1. No data were found to increase hazard (h) or mechanism (m) scores for infants. Sources: DSM Syn‑HYCAN brochure, EPA CompTox, EWG listing noting concern but not providing reproductive/infant data.
- 생후 6개월 미만 아기에게 tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate을(를) 써도 되나요?
- tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate의 아기 피부 데이터가 없습니다. 알려진 위험 없는 성분을 우선하세요.
- 아기를 위한 tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate의 더 안전한 대안은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
- VeriMom은 tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate을(를) 아기 피부 기준으로 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate을 93/100 (알려진 위험 없음)로 평가합니다.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.